EPISODE · Jan 28, 2025 · 25 MIN
Velmanase alfa for alpha-mannosidosis
from JIMD Podcasts · host Journal of Inherited Metabolic Disease
Nathalie Guffon joins the podcast to discuss alpha-mannosidosis and the long term efficacy of enzyme replacement therapy with velmanse alfa. Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosis Nathalie Guffon, et al https://doi.org/10.1002/jimd.12799
Embed this episode
NOW PLAYING
Velmanase alfa for alpha-mannosidosis
0:00
25:34
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JIMD Podcasts?
This episode is 25 minutes long.
When was this JIMD Podcasts episode published?
This episode was published on January 28, 2025.
Can I download this JIMD Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!